Related Experiment Video
Updated: Jan 17, 2026

Spectral Karyotyping to Study Chromosome Abnormalities in Humans and Mice with Polycystic Kidney Disease
Published on: February 3, 2012
Two Siblings With Al Kaissi Syndrome: Clinical, Radiological, and Molecular Characterization of Compound Heterozygous
Zehra Manav Yigit1,2, Aydan Mengubas Erbas1, Ridvan Savas1
1Medical Genetics Department, Aydin Adnan Menderes University, Faculty of Medicine, Aydin, Turkey.
None:
Al Kaissi syndrome is a rare autosomal recessive neurodevelopmental disorder resulting from biallelic loss-of-function variants in the CDK10 gene. Cyclin-dependent kinase 10 (CDK10) encoded protein plays essential roles in cell cycle regulation, transcriptional control, and ciliogenesis. We report two male siblings presenting with developmental delay, dysmorphic facial features, and skeletal anomalies. Comprehensive clinical, radiological, and molecular genetic evaluations were performed on the affected individuals and their parents, including exome sequencing. Both siblings were found to carry compound heterozygous pathogenic variants in CDK10: a previously reported splice-site variant (c.609-1G > A) and a frameshift variant (c.520_521del), previously unreported in clinical cases. The clinical phenotype in both cases was consistent with Al Kaissi syndrome, including intellectual disability, facial dysmorphisms, spinal malformations, and delayed developmental milestones. This report presents the first Turkish cases of Al Kaissi syndrome with compound heterozygous CDK10 variants and thoroughly reviews previously reported cases. This expands the known phenotypic and genotypic spectrum of the disorder.
Related Concept Videos
Karyotyping
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity

